Cytologic and Biochemical Studies on the Granulocytes in Early Leukemia Among Atomic Bomb Survivors
Texas Reports on Biology and Medicine, 1954. Reprinted from Texas Reports on Biology and Medicine, Volume 12, Number 4, pages 887-897, Winter 1954. Wraps. Pages 887-897, [1] pages. Tables. References. Hole through several pages. Stamp and ink notations on front page. During the medical surveys of adult atomic bomb survivors carried out in the Atomic Bomb Casualty Commission Clinic in Hiroshima, nine cased of leukemia were encountered. An account of these cases is presented in this report. William Curry Moloney, MD, who studied and treated blood diseases before hematology became a medical specialty, was a professor emeritus of medicine at Harvard Medical School and former director of hematology at Brigham and Women's Hospital. He was one of the first hematologists to use chemotherapy to treat leukemia and lymphoma. Dr. Moloney was also an early contributor to the development of specific diagnostic tests, some of which are still in use today. Dr. Moloney was a recognized authority on safe procedures for blood transfusions, and his expertise in blood banks stood him in good stead in World War II, when he oversaw transfusions to wounded soldiers. After the war, in the early 1950s, Dr. Moloney directed research for the Atomic Bomb Casualty Commission in Hiroshima, Japan. Later, in the Marshall Islands, he studied the effects of errant radiation and the mechanisms that produce leukemia. More